HIGHFDA DRUG

Nivagen Zinc Oxide Ointment Recall 912 Containers Over cGMP Deviations (2025)

Nivagen Zinc Oxide Ointment 20% skin protectant, manufactured in India for Nivagen Pharmaceuticals and distributed nationwide in the USA, is recalled. The recall covers 912 containers. The defect cited is cGMP deviations. Consumers and healthcare providers should stop using the product and follow guidance from Blossom Pharmaceuticals or a healthcare professional.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
October 31, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
October 31, 2025
Hazard Level
HIGH
Brand
Nivagen Zinc Oxide
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Nivagen Zinc Oxide
Product type
Zinc Oxide Ointment
Model numbers
A352318
UPC codes
75834-170, 75834-170-01, 75834-170-02, 75834-170-15
Sizes
15 oz (425 g)
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 31, 2025

  2. Reported by FDA DRUG

    December 10, 2025

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

cGMP deviations

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Blossom Pharmaceuticals or your healthcare provider for guidance. Notification method: Letter

About This Product

Zinc oxide ointment is a topical skin protectant used to soothe and protect irritated skin. The 20% formulation is a high-concentration variant used in medical settings.

Why This Is Dangerous

cGMP deviations indicate manufacturing quality control issues that could affect product safety or potency. This may compromise product integrity until resolved.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Consumers and healthcare providers should treat this as a quality issue and use non-affected products until further guidance is issued.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the container: A352318.
  2. Verify the NDC on the packaging: 75834-170-15.
  3. Confirm net weight: 15 oz (425 g).
  4. Note the product is manufactured in India for Nivagen Pharmaceuticals, Inc.

Where to find product info

FDA enforcement report page for D-0206-2026. Recall notices may also be distributed by Blossom Pharmaceuticals.

What timeline to expect

Refunds or replacements, if available, typically follow 4-6 weeks after recall confirmation.

If the manufacturer is unresponsive

  • Document all contact attempts with Blossom Pharmaceuticals.
  • Escalate to the FDA recall contact if the company is unresponsive.
  • Consider filing a consumer complaint with CPSC if product misuse results in harm.

How to prevent similar issues

  • Verify product origin and lot numbers when purchasing zinc oxide ointments.
  • Buy from reputable retailers with clear recall policies.
  • Keep product packaging until recall is resolved.

Documentation advice

Keep the product packaging, store receipt if available, and all recall notices and correspondence with the company.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Nivagen Zinc Oxide. Product: Zinc Oxide Ointment USP 20% Skin Protectant. Net weight: 15 oz (425 g). NDC: 75834-170-15. Lot: A352318. Manufactured in: India. Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA. Quantity recalled: 912 containers. Distribution: USA Nationwide. Sold from: Not disclosed. Recall date: 2025-10-31. Status: ACTIVE. Price: Unknown.

Key Facts

  • 912 containers recalled nationwide
  • Manufactured in India for Nivagen Pharmaceuticals, Inc.
  • Active recall status as of 2025-12-10

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
A352318
UPC Codes
75834-170
75834-170-01
75834-170-02
+1 more
Affected States
ALL
Report Date
December 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more